A study to evaluate the effect of nolasiban on uterine contractions in women undergoing IVF or ICSI treatments
- Substances:–
Spain- Participants:18–64 years
- Sponsor:ReproNovo ApS
Rare diseases
Investigational molecules
Locations
Calle De Zurbano 51, 28010 Madrid, Spain
Ginefiv S.L. in Madrid, Spain specialises in clinical trials of conditions such as Infertility female, Controlled ovarian stimulation, and other specialisations. This site conducts important research.
At Ginefiv S.L. the focus is on improving outcomes for women facing female infertility and those undergoing assisted reproductive technologies. Current studies compare different pituitary suppression methods during double ovarian stimulation to increase the number of euploid embryos for preimplantation genetic testing.
These investigations aim to refine stimulation regimens, enhance embryo quality, and expand treatment options for patients indicated for IVF/ICSI.
Research at the clinic also explores how uterine activity influences implantation success in women undergoing IVF. An exploratory trial evaluates the effects of nolasiban on uterine contractility and its potential to improve pregnancy outcomes.
By targeting uterine contractility, the studies hope to reduce implantation failure and support healthier pregnancies for those with pregnancy complications.
Clinical trials currently enrolling participants at this site.
Spain
Spain
SpainMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.